Creating advanced treatments for head and neck cancer using implantable devices
Development and optimization of highly effective treatments in patients with head and neck cancer using in situ implantable microdevices
This study is testing new tiny devices that can deliver cancer treatments right to tumors in people with head and neck cancer, helping doctors find the best options for each patient while aiming to improve results and lessen side effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11027024 on NIH RePORTER |
What this research studies
This research focuses on developing innovative implantable microdevices that can deliver small doses of various cancer treatments directly to tumors in patients with head and neck cancer. By measuring how the tumor responds to each treatment, the research aims to identify the most effective therapies tailored to individual patients. This personalized approach could significantly improve treatment outcomes and reduce side effects by ensuring that patients receive the most suitable therapies based on their unique tumor characteristics.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with head and neck cancer who are seeking personalized treatment options.
Not a fit: Patients with cancers other than head and neck cancer may not benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with head and neck cancer.
How similar studies have performed: Previous research has shown promising results with similar implantable microdevice technologies in predicting treatment responses in other cancer types.
Where this research is happening
Boston, United States
- Brigham and Women's Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Jonas, Oliver — Brigham and Women's Hospital
- Study coordinator: Jonas, Oliver
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.